期刊文献+

健康教育对视网膜母细胞瘤患儿亲属的影响 被引量:1

Impact of health education to relatives of retinoblastoma child
下载PDF
导出
摘要 目的探讨健康教育对视网膜母细胞瘤(retinoblastoma,RB)患儿亲属的影响。方法收集眼科收治确诊为RB住院患儿家属60例,通过自制资料,针对RB家属进行健康教育和未对RB家属进行健康教育的特点进行调查对比。结果与未对RB家属进行健康教育组比较,进行健康教育组患儿亲属在心理状态、对患儿疾病的认识、疾病预后的理解、饮食的了解、安装义眼的护理、复查时间、遗传咨询等方面差异均有统计学意义(P<0.05)。结论对RB患儿亲属进行健康教育,能使他们获得消除焦虑、恐惧的方法以及疾病的相关知识,并有效地向患儿提供护理和帮助,使之积极配合治疗,提高治疗效果,并促使护士不断学习,提高业务素质和健康教育能力及家属对医疗护理质量的满意度。 Objective To explore the impact of health education to the relatives of retinoblastoma(RB) child. Methods 60 cases of family relatives in RB inpatients in the ophthalmology department of our hospital were collected and performed the health education. The characters of RB family relatives with health education and RB family relatives without health education were investigated and compared by self-made data. Results Compared with the non health education group,the family relatives of the health education group had statistical difference in the aspects of psychological status,understanding of the disease and prognosis, knowledge of diet, nursing of the artificial eye, review over time and genetic counseling (P〈0.05). Conclusion Health education on the relatives of RB children enable them to obtain a good way to eliminate anxiety and fear, and a good knowledge of the disease, to provide nursing and assistance effectivgly, to actively cooperate with treatment, improve the therapeutic effect, and to prompt the nurses to keep on learning, improve their professional quality and health education capability, to improve the satisfaction of the family relatives to the quality of medical care.
出处 《现代医药卫生》 2012年第11期1643-1644,共2页 Journal of Modern Medicine & Health
关键词 视网膜母细胞瘤 家庭 健康教育 影响 Retinoblastoma Family Health education Effect
  • 相关文献

参考文献7

二级参考文献10

共引文献55

同被引文献17

  • 1刘万丽,吴中耀,杨华胜,颜建华.视网膜母细胞瘤的生存率和预后因素研究[J].中华临床医师杂志(电子版),2010,4(5):597-602. 被引量:8
  • 2Vajzovic LM, Murray TG, Aziz - Sultan MA, et al. Supraselective in- tra- arterial chemotherapy:evaluation of treatment- related compli- cations in advanced retinoblastoma [ J ]. Clin Ophthalmol, 2011,5 : 171 - 176.
  • 3Linn Murphree A. Intraocular retinoblastoma the case for a new group classificationE J:. Ophthalmol Clin North Am,2(X: ,18( 1 ) :41 -53.
  • 4Shields CL, Shields JA. Diagnosis and management of retinoblasto- ma[ J]. Cancer Control. 2004,11 (5) :317 -327.
  • 5Kim J-W, Abranlson DI4, Dunkel U. Current management strategies for intraocular retinoblastoma[ J ]. Drugs ,2007,67 (15) :2173 - 2185.
  • 6Shields CL, Shelil A, Cater J, et al. Development of new retinoblas- tomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients[ J]. Arch Ophthalmol,2003,121 (11) :1571 - 1576.
  • 7Rodriguez - Galindo C, Chantada GL, Haik BG, et al. Treatment ofretinob|astoma: current status and future perspectives [ J ]. Curt Treat Options Neuro1,2007,9 (4) :294 - 307.
  • 8郑刚,李成建,王景禄.替尼泊苷过敏反应[J].中国误诊学杂志,2007,7(28):6949-6950. 被引量:7
  • 9马文芳,梁苑,余惠英.高危视网膜母细胞瘤患者的术后辅助化疗护理[J].现代医院,2008,8(9):80-82. 被引量:4
  • 10郑嵩山,吴中耀,杨华胜,颜建华,毛羽翔.视网膜母细胞瘤317例临床分析[J].眼科研究,2008,26(8):627-629. 被引量:17

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部